Ernesto Abel-Santos

Professor, Biochemistry
Expertise: Bacterial Spore Germination, Bio-organic Chemistry, Bioterrorism, Enzymology

Biography

Ernesto Abel-Santos’ research combines the areas of organic chemistry, biochemistry and microbiology. In his lab, Abel-Santos works with bacterial spores, including anthrax and the hospital infection, Clostridium difficile (C-diff). He also is part of a collaborative research group looking at bacteria that affects chickens and honeybees. 

Abel-Santos developed new techniques for evaluating mechanisms of Bacillus and Clostridium spore germination. He also investigates new methods to control anthrax infections, which are resistant to most antiseptic and antibiotic treatments. He has developed nucleoside inhibitors against anthrax spore germination.

He is the co-founder of Able Therapeutics LLC, a start up company that is researching, developing, and commercializing the first and only preventative medicine for treating Clostridium difficile, one of the fastest growing epidemics in the U.S. C-diff spores can be contracted anytime a patient is in a hospital, nursing home, surgery center, or other similar facility.

Education

  • Ph.D., Bioorganic Chemistry, Washington School of Medicine, St. Louis, Missouri
  • B.S., Chemistry, Universidad Autónoma de Santo Domingo, Dominican Republic

Search For Other Experts On

science & technology

Ernesto Abel-Santos In The News

NDTV Food
February 14, 2020
Want to lose some weight? Opt for low carb and high protein diet! This is the go-to suggestion every second person advises. But did you know this may lead to alleviation of hospital-acquired infections? A recent study says so.
Medindia
February 14, 2020
Diet low in carbohydrates, high in fat and protein can be good for the waistline, but new study shows that just the opposite may help to reduce the hospital-acquired infection caused by Clostridioides difficile. The study appears in mSystems, an open access journal of the American Society for Microbiology.
Devdiscourse
February 14, 2020
In contrast with the popular opinion that low carb and high protein diets help in maintaining the waistline, a new study suggests that the same may lead to alleviation of hospital-acquired infections. The study surrounding the hospital-acquired infection Clostridioides difficile was published in the journal mSystems.
Newswise
February 12, 2020
Popular diets low in carbs and high in fat and protein might be good for the waistline, but a new UNLV study shows that just the opposite may help to alleviate the hospital-acquired infection Clostridioides difficile.

Articles Featuring Ernesto Abel-Santos

chalk drawing of human body with intestinal tract
ResearchFebruary 12, 2020
New UNLV study shows promise for role of a high-carb, low-protein, and low-fat diet in fighting off C. diff infections.
Katelyn DiBenedetto holds an arrowhead
ResearchOctober 20, 2016
From finances to energy, health care, and more, UNLV graduate student researchers are asking important questions about America’s future.
ResearchDecember 1, 2015
UNLV has reached a licensing agreement with Abel Therapeutics, a start-up company that seeks to commercialize the discoveries of biochemistry professor Ernesto Abel-Santos.
ResearchApril 17, 2014
Chemistry professor developing treatment to help the good bacteria battle the bad bacteria in your stomach.